Study of Some Risk Factors in Acute Exacerbation of COPD at Tertiary Care Centre

Jump To References Section

Authors

  • Juhi R. Kadukar
     Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra ,IN
  • Ramesh Sundrani
     Professor and Head, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra ,IN
  • Sushma Dugad
     Associate Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra ,IN
  • Gauri Suhas Kulkarni
     Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra ,IN
  • Jaspreet Singh Khandpur
     PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra ,IN
  • Maya Mortale
     Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Nashik - 422203, Maharashtra ,IN

DOI:

https://doi.org/10.18311/mvpjms/2020/v7i1/22912

Keywords:

Biomass Fuel, COPD, Improper Inhaler Technique, Indoor and Outdoor Pollution

Abstract

Background: Respiratory symptoms of patients usually worsen, which may be beyond normal day to day variation this is nothing but an acute event of a disease leading to further change in medication. Acute exacerbation of Chronic obstructive pulmonary disease is defined as sudden worsening of symptoms like in breathlessness, chest pain, change in quantity and colour of sputum, fever, these symptoms usually last for several days. These symptoms are aggravated by environmental pollutants, bacterial and viral infections wherein infections usually lead to 75% or more of the exacerbations but improper inhaler technique is also one of the most important factors for causing exacerbation of Chronic Obstructive Pulmonary disease. Aims and Objectives: To study the risk factors for exacerbation of COPDs. Methods: Present sample consists of 51 diagnosed COPD patients who fulfilled eligibility criteria. Study was conducted in the department of Respiratory medicine from August 2016 to December2018. Detailed history along with general and respiratory system examination was done and findings were recorded. Results: Most of the study population was present between 51 to 60 years (41.2%) of age group and rest were in 41 to 50 years (29.4%) and more than 60 years (29.4%). There was male predominance (64.7%) amongst study population as compared to females (35.3%). 82.4% of study population were taking inhaler improperly. 64.7 % of study population were exposed to outdoor pollution. 43.1% of study population are exposed to indoor pollution. Conclusion: Environmental stress are also involved in acute exacerbation of chronic obstructive pulmonary disease apart from viral and bacterial infections. Improper technique of using inhaler was also the main risk. So patients are advised proper & regular use of inhaler technique. Indoor and outdoor pollution is also main risk factor for exacerbation so avoidance of exposure to biomass fuel and outdoor pollution should be considered.

Downloads

Published

2021-03-10

Issue

Volume 7, Issue 1, January - June 2020

Section

Original Research Article

 

References

Stockley RA. Neutrophils and the pathogenesis of COPD. Chest. 2002 May 1;121(5):151S-5S. https://doi.org/10.1378/ chest.121.5_suppl.151S. PMid:12010844.

Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998; 4:1241-3. https://doi.

org/10.1038/3218. PMid:9809543.

Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 1998 May 1;157(5):1418-22. https://doi.org/10.1164/ajrccm.157.5.9709032. PMid:9603117.

Pauwels R, Calverley P, Buist AS, Rennard S, Fukuchi Y, Stahl E, Löfdahl CG. COPD exacerbations: the importance of a standard definition. Respiratory medicine. 2004 Feb 1;98(2):99-107. https://doi.org/10.1016/j.rmed.2003.09.001. PMid:14971871.

Connors Jr AF, Dawson NV, Thomas C, Harrell Jr FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). American journal of respiratory and critical care medicine. 1996 Oct;154(4):959-67. https://doi.org/10.1164/ajrccm.154.4.8887592. PMid:8887592.

Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest. 1995 Aug 1;108(2):43S-52S.

Sunyer J, Saez M, Murillo C, Castellsague J, Martinez F, Antó JM. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. American journal of epidemiology. 1993 Apr 1;137(7):7015.

Carilli AD, Gohd RS, Gordon W. A virologic study of chronic bronchitis. N Engl J Med. 1964; 270:123-7. https://doi.org/10.1056/NEJM196401162700303. PMid:14067009.

Monto AS, Bryan ER. Susceptibility to rhinovirus infection in chronic bronchitis. Am Rev Respir Dis. 1978; 118:11013.

Smith CB, Golden CA, Kanner RE, Renzetti AD Jr. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis. 1980; 121:225-32.

Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2000 Jul 1;162(1):167-73. https://doi.org/10.1164/ajrccm.162.1.9911019. PMid:10903237.

Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respiratory care. 2003 Dec 1;48(12):1204-15. https://doi.org/10.1201/9780203913406.ch9.

Stenhouse AC. Viral antibody levels and clinical status in acute exacerbations of chronic bronchitis: a controlled prospective study. Br Med J. 1968 Aug 3;3(5613):287-90. https://doi.org/10.1136/bmj.3.5613.287. PMid:4299087 PMCid:PMC1986246.

Seemungal TA, Harper"Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. European Respiratory Journal. 2000 Oct;16(4):67783. https://doi.org/10.1034/j.1399-3003.2000.16d19.x. PMid:11106212 PMCid:PMC7163563.

Hasan A, Ashraf MU, Naaz S, Bhargava R, Ashraf J. A study of clinical and echocardiographic profile of patients of chronic obstructive pulmonary disease helping in early diagnosis of Corpulmonale. International Journal of Enhanced Research in Medicines and Dental care, ISSN. 2014:2349-1590.

Guleria JS, Pande JN, Gupta RG. Chronic obstructive lung disease in Northern India. American Review of Respiratory Disease. 1969 Oct;100(4):490-8.

Dirkje PS, Huib KAM. Epidemiology and natural history of chronic obstructive pulmonary disease. John GG, Duncan GM, Ulrich C, Peter SJ, Bryan C, editors. Respiratory Medicine. 3rd ed. Saunders; 2003. p. 1109-1120.

Rachaiah NM, Rachaiah JM, Bhadravathi RK. A correlative study of spirometric parameters and ECG changes in patients with chronic obstructive pulmonary disease. Int J Biol Med Res. 2012; 3(1):1322-6.

Narayanagowda DS, Golia S, Jaiswal J, Manasa SS. A bacteriological study of acute exacerbation of chronic obstructive pulmonary disease over a period of one year. Int J Res Med Sci 2015; 3:3141-6. https://doi.org/10.18203/23206012.ijrms20151152.

Ganguly A, Das AK, Roy A. Study of proper use of inhalation devices by bronchial asthma or COPD patients attending a tertiary care hospital. J Clin Diagn Res. 2014; 8(10):HC047. https://doi.org/10.7860/JCDR/2014/9457.4976. PMid:25478367 PMCid:PMC4253185.

Molimard M, Rahersion C, Lignot S. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: Real-life assessment of 2935 patients. Eur Respir J. 2017; 49(2). https://doi.org/10.1183/13993003.017942016. PMid:28182569.